D122-0041 Screening compound: 2-(2-chlorophenyl)-1-(4-{7-hydroxy-3-[(thiophen-2-yl)methyl]-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-yl}piperidin-1-yl)ethan-1-one

D122-0041 Screening compound: 2-(2-chlorophenyl)-1-(4-{7-hydroxy-3-[(thiophen-2-yl)methyl]-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-yl}piperidin-1-yl)ethan-1-one
D122-0041 Screening compound: 2-(2-chlorophenyl)-1-(4-{7-hydroxy-3-[(thiophen-2-yl)methyl]-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-yl}piperidin-1-yl)ethan-1-one alternative view

Chemical Structure Depiction of ChemDiv screening compound D122-0041
2-(2-chlorophenyl)-1-(4-{7-hydroxy-3-[(thiophen-2-yl)methyl]-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-yl}piperidin-1-yl)ethan-1-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D122-0041

Molecular Formula

C22H21ClN6O2S (C22 H21 ClN6 O2 S)

Compound Name

2-(2-chlorophenyl)-1-(4-{7-hydroxy-3-[(thiophen-2-yl)methyl]-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-yl}piperidin-1-yl)ethan-1-one

IUPAC name

2-(2-chlorophenyl)-1-(4-{7-hydroxy-3-[(thiophen-2-yl)methyl]-3H-[123]triazolo[45-d]pyrimidin-5-yl}piperidin-1-yl)ethan-1-one

SMILES

Oc1c2nnn(Cc3cccs3)c2nc(C(CC2)CCN2C(Cc(cccc2)c2Cl)=O)n1

InChI

InChI=1S/C22H21ClN6O2S/c23-17-6-2-1-4-15(17)12-18(30)28-9-7-14(8-10-28)20-24-21-19(22(31)25-20)26-27-29(21)13-16-5-3-11-32-16/h1-6,11,14H,7-10,12-13H2,(H,24,25,31)

InChI Key

TWIBOJIXNODGID-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14812154

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

468.97

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.190

Distribution Coefficient, logD

2.736

Water Solubility, LogSw

-3.12

Polar Surface Area

79.693

Acid Dissociation Constant (pKa)

7.13

Base Dissociation Constant (pKb)

0.94

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

31.80

D122-0041 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

C-Met Library (15277 compounds)

GPCR Targeted Library (31838 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Endocrine
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • Kinases
  • GPCR
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • Receptor's ligands
  • Receptor's ligands

References: we are preparing a list of scientific research reports with D122-0041 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound D122-0041?
Check Price and Availability of D122-0041, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of D122-0041 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for D122-0041
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for D122-0041
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of D122-0041 available by request